Literature DB >> 12225874

JunB and Bcl-2 overexpression results in protection against cell death of nigral neurons following axotomy.

Christine Winter1, Christoph Weiss, Ana Martin-Villalba, Manfred Zimmermann, Johannes Schenkel.   

Abstract

Transection of the medial forebrain bundle is a well established approach to investigate neuronal cell body response in the derived neuronal populations of the substantia nigra pars compacta (SNC). This model of central axotomy leads in mouse within 50 days post transection to degeneration of up to 70% of the affected SNC neurons. A central component of the axotomy induced alterations leading to neuronal degeneration is the rapid induction, lasting expression and activation of the c-Jun transcription factor. However, the role of c-Jun in the process of neuronal degeneration is not fully understood. Since null mutations of c-Jun cause embryonic lethality, this study was designed to investigate the impact of two c-Jun modulating proteins on neuronal survival after axotomy in transgenic mice: JunB, a Jun family member affecting c-Jun expression, and Bcl-2, an antiapoptotic protooncogene interacting among others with the c-Jun N-terminal kinases. In JunB as well as in Bcl-2 transgenic mice the long term survival rate of transected SNC neurons was remarkably increased when compared to wildtype controls. These effects were obviously achieved by cellular modulations directly following axotomy: Whereas JunB overexpression attenuated c-Jun induction and simultaneously led to a higher phosphorylation rate of c-Jun in SNC neurons, Bcl-2 overexpression did not influence c-Jun expression, but resulted in a reduced phosphorylation state of c-Jun in transected SNC neurons. We therefore conclude that the early phosphorylation rate of c-Jun might play an important role for the long term fate of transected neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225874     DOI: 10.1016/s0169-328x(02)00378-9

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Transient protective effect of B-vitamins in experimental epilepsy in the mouse brain.

Authors:  Tamer Rabie; Wolfgang Mühlhofer; Thomas Bruckner; Anna Schwab; Alexander T Bauer; Manfred Zimmermann; Dieter Bonke; Hugo H Marti; Johannes Schenkel
Journal:  J Mol Neurosci       Date:  2009-09-24       Impact factor: 3.444

2.  Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease.

Authors:  Vellareddy Anantharam; Elin Lehrmann; Arthi Kanthasamy; Yongjie Yang; Probal Banerjee; Kevin G Becker; William J Freed; Anumantha G Kanthasamy
Journal:  Neurochem Int       Date:  2007-02-23       Impact factor: 3.921

3.  Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern.

Authors:  Kerstin Leykauf; Kirsten Kabsch; Nikolaus Gassler; Lutz Gissmann; Angel Alonso; Johannes Schenkel
Journal:  Transgenic Res       Date:  2007-08-16       Impact factor: 2.788

4.  Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.

Authors:  Ravi S Akundi; Zhenyu Huang; Joshua Eason; Jignesh D Pandya; Lianteng Zhi; Wayne A Cass; Patrick G Sullivan; Hansruedi Büeler
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

5.  Excitotoxic stimulation activates distinct pathogenic and protective expression signatures in the hippocampus.

Authors:  Ebru Caba; Marcus D Sherman; Karen L G Farizatto; Britney Alcira; Hsin-Wei Wang; Charles Giardina; Dong-Guk Shin; Conner I Sandefur; Ben A Bahr
Journal:  J Cell Mol Med       Date:  2021-08-20       Impact factor: 5.310

6.  Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson's Disease.

Authors:  Tatiana Usenko; Anastasia Bezrukova; Katerina Basharova; Alexandra Panteleeva; Mikhail Nikolaev; Alena Kopytova; Irina Miliukhina; Anton Emelyanov; Ekaterina Zakharova; Sofya Pchelina
Journal:  Genes (Basel)       Date:  2021-09-29       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.